Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours.
Van Der Horst-Schrivers
Anouk N A
AN
Slot
Madeleine H E Bruins
MH
Willemse
Pax H B
PH
Kema
Ido P
IP
De Vries
Elisabeth G E
EG
Wymenga
A N Machteld
AN
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017209:Apoptosis; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects; D018358:Neuroendocrine Tumors / Q000097:blood / Q000188:drug therapy* / Q000556:secondary*; D017211:Treatment Failure; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000187:drug effects*
D020533:Angiogenesis Inhibitors; D007155:Immunologic Factors; D016898:Interferon-alpha; D042461:Vascular Endothelial Growth Factor A; D005472:Fluorouracil